UNSPSC 85892129: Low dose rate (ldr) brachytherapy of larynx using iridium 192 (ir-192)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of low dose rate (ldr) brachytherapy of larynx using iridium 192 (ir-192). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D91BB8Z

UNSPSC 85892129 Low dose rate (ldr) brachytherapy of larynx using iridium 192 (ir-192) is a Commodity code with little relevant recent activity in state and local procurement. The recent opportunity posted under this code—Santa Clara County Health System's request for temporary health professional staffing services across ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, ophthalmology, orthopedic services, respiratory care, sterile processing, surgical and operating room services, and therapy services—does not align with the code's narrow scope of oncological brachytherapy treatment. The staffing solicitation covers multiple non-clinical ancillary professional placements, whereas the code nominally describes a specific therapeutic procedure involving radioactive implant placement for laryngeal cancer. This mismatch suggests either a tagging error in the County's procurement system or that the code has been applied too broadly to general health services procurement, rather than to the specialized interventional oncology procedures the code is designed to capture.

The Santa Clara County Health System RFP (RFSQHHSFY270052) represents a non-exclusive, multiple-award vehicle with no guaranteed minimum work volume, allowing proposers to self-select categories and responses due October 7, 2026. The County maintains discretion to hold the Qualified List for five years and contract with selected vendors as operational needs arise. Without additional state or local opportunities specifically targeting brachytherapy services, radiation oncology equipment, or related therapeutic implant procurement under this code, the activity profile remains unclear. Firms with brachytherapy capabilities should not rely on this code classification as a leading indicator of relevant state and local demand and should track broader oncology service and equipment categories for more targeted opportunities.